CClinicalTrials.gg
CompletedNCT02341196Updated Jan 19, 2015

Randomized Clinical Trial of Polyester vs. Polyurethane Patch for Carotid Endarterectomy

An interventional study of CEA in Carotid Artery Thrombosis, Carotid Artery Stenosis and Stroke, sponsored by University of Poitiers. Completed. Open to participants aged 25 Years to 90 Years. Per ClinicalTrials.gov, last updated 2015-01-19.

Sponsored by University of Poitiers · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Randomized
Ages
25 Years to 90 Years
Sex
All
01

Study summary

This study examines the risk of thrombogenicity of the carotid patches in polyurethane compared to carotid patches in polyester including death, any stroke, carotid thrombosis at 30 days and long-term results including stroke and recurrent carotid stenosis at 10 years.

This study was run at the University of Roma, La Sapienza and at the University of Poitiers, randomisation was done in both enters after approval by the Ethical committee of the University of Roma (Record uploaded)

Read the detailed description

This study examines the risk of thrombogenicity of the carotid patches in polyurethane compared to carotid patches in polyester including death, any stroke, carotid thrombosis at 30 days and long-term results including stroke and recurrent carotid stenosis at 10 years.

598 patients were considered for randomisation between January 1995 and January 2004. The following patients were excluded for randomisation (Redo carotid surgery: N=34, radiation induced carotid stenosis:N=45, indication for carotid bypass: N=65, Refusal of randomisation: N=4).

In total, 450 patients were randomized in two groups, 225 received a polyester patch and 225 received a polyurethane patch.

All patients were operated under general anaesthesia and all received an intraoperative angiography. A shunt was selectively used in patients with a recent stroke (\<15 days) or with a contralateral carotid occlusion

02

Conditions studied

  • Carotid Artery Thrombosis
  • Carotid Artery Stenosis
  • Stroke
03

In context

Carotid Stenosis

339 studies on the registry are indexed under Carotid Stenosis; 81 are open to participants now.

This study's enrollment of 450 is above the median of 106 across 182 interventional studies indexed under Carotid Stenosis.

Browse Carotid Stenosis studies →

Lead sponsor

University of Poitiers is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Carotid stenosis > 60% NASCET criteria

Exclusion criteria

Exclusion Criteria:

  • Redo carotid surgery
  • Radiation induced carotid stenosis
  • Extensive carotid lesion > 5 cm in length with involvement of the common carotid artery best treated by a carotid bypass
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
450 participants (actual)

Study arms

  • Experimental
    CEA + Polyester patch

    225 Patients

    Procedure: CEA

  • Experimental
    CEA + Patch Polyurethane

    225 Patients

    Procedure: CEA

Interventions

  • ProcedureCEA

    Patients in both groups received an intra-operative angiography

    Also known as: Carotid endarterectomy

06

What researchers measure

Primary outcomes

  1. carotid artery restenosis

    Restenosis of carotid endarterectomy \> 70% in diameter occurring 5 to 10 years after surgery diagnosed by color duplex ultrasound

    Time frame: 5 to 10 years after surgery

Secondary outcomes

  1. Any death occurring during follow-up

    All death even those not related to carotid surgery

    Time frame: Time 0 (operation) to 10 years after surgery

  2. Any ipsilateral stroke

    Any paralysis occurring in relation with the operated carotid artery and lasting more than 24 hours

    Time frame: 0 days to 10 years

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 19, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02341196
Lead sponsor
University of Poitiers
Collaborators
University of Roma La Sapienza
Responsible party
Sponsor
First posted
Jan 19, 2015
Start date
Jan 1995
Primary completion
Jan 2004
Completion
Dec 2014
Last update
Jan 19, 2015

Study contacts

Giulio Illuminati, MD, PhD
study chair · University of Roma La Sapienza

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion